Post-stroke language impairment adds thousands to medical costs

February 16, 2012 in Cardiology

Stroke-related language impairment adds about $1,703 per patient to medical costs the first year after stroke, according to research reported in Stroke: Journal of the American Heart Association.

Researchers retrospectively examined the records of 3,200 South Carolina who had in 2004 and found:

  • Twelve percent (398 patients) had aphasia or language impairment.
  • for those with aphasia averaged $20,734 per patient vs. $18,683 for those without it — an 8.5 percent increase.
  • Aphasia patients were older and had more severe strokes.
  • Aphasia patients stayed in healthcare facilities 6.5 percent longer and had higher rates of illness and death.
"These findings are important because dramatic changes are occurring in healthcare reimbursement, specifically imposed caps on Medicare reimbursement for outpatient speech language pathology and physical therapy," said Charles Ellis Jr., Ph.D., lead author and associate professor of Health Sciences and Research at the Medical University of South Carolina in Charleston. "Although the current reimbursement cap is $1,870 for these therapies, the financial burden of the cap remains a major limiting factor to access long-term rehabilitation for patients with persisting aphasia."

Annually, about 100,000 people who suffer a stroke will be left with language deficits due to aphasia.

Provided by American Heart Association search and more info website

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Related Stories
Relevant PhysicsForums posts

More news stories

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created 10 hours ago | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created 13 hours ago | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created 13 hours ago | popularity not rated yet | comments 0

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Cardiology created 13 hours ago | popularity not rated yet | comments 0

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...

Cardiology created May 21, 2013 | popularity 5 / 5 (1) | comments 0


Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.

Researchers complete largest genetic sequencing study of human disease

Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.

Having both migraines, depression may mean smaller brain

(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.

Novel approach for influenza vaccination shows promise in early animal testing

A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...

Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis

In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...